Xiaolan Lu

1.3k total citations
27 papers, 926 citations indexed

About

Xiaolan Lu is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Xiaolan Lu has authored 27 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Xiaolan Lu's work include MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Xiaolan Lu is often cited by papers focused on MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Xiaolan Lu collaborates with scholars based in China, United States and Czechia. Xiaolan Lu's co-authors include Cheng Wang, Chen‐Yu Zhang, Meng Ding, Xiaokang Wu, Xue Li, Cuiping Zhang, Yaofeng Jin, Ming Li, Yan Geng and Jiali Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Xiaolan Lu

27 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Lu China 16 570 230 147 107 101 27 926
Kun Ren China 22 636 1.1× 388 1.7× 131 0.9× 64 0.6× 115 1.1× 66 1.4k
Yuting Wang China 18 462 0.8× 99 0.4× 59 0.4× 61 0.6× 71 0.7× 81 1.2k
Hongli Yan China 23 476 0.8× 251 1.1× 211 1.4× 42 0.4× 90 0.9× 72 1.3k
Wanqian Li China 17 406 0.7× 176 0.8× 67 0.5× 56 0.5× 81 0.8× 44 924
Amir Savardashtaki Iran 16 768 1.3× 463 2.0× 60 0.4× 79 0.7× 47 0.5× 31 1.4k
Shilong Zhang China 18 588 1.0× 180 0.8× 117 0.8× 131 1.2× 17 0.2× 95 1.2k
Xiaohui Ma China 17 291 0.5× 62 0.3× 85 0.6× 98 0.9× 59 0.6× 55 756
Fangming Song China 21 619 1.1× 128 0.6× 71 0.5× 36 0.3× 33 0.3× 49 948
Binbin Cheng China 25 864 1.5× 271 1.2× 161 1.1× 56 0.5× 15 0.1× 70 1.5k
Zhipeng Su China 19 622 1.1× 250 1.1× 84 0.6× 85 0.8× 29 0.3× 76 1.3k

Countries citing papers authored by Xiaolan Lu

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Lu more than expected).

Fields of papers citing papers by Xiaolan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Lu. The network helps show where Xiaolan Lu may publish in the future.

Co-authorship network of co-authors of Xiaolan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Lu. A scholar is included among the top collaborators of Xiaolan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Lu. Xiaolan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Gang, Tao Gao, Huimin Lu, et al.. (2024). Type 3 deiodinase activation mediated by the Shh/Gli1 axis promotes sepsis-induced metabolic dysregulation in skeletal muscles. Burns & Trauma. 13. tkae066–tkae066. 2 indexed citations
2.
Wang, Shengnan, et al.. (2024). Three patients with new mutations in the EPCAM variant gene for congenital tufting enteropathy and a mutation review in China: a case report. Translational Pediatrics. 13(8). 1486–1495. 1 indexed citations
3.
Bai, Dan, et al.. (2023). DNA Methylation Modification Patterns Identify Distinct Prognosis and Responses to Immunotherapy and Targeted Therapy in Renal Cell Carcinoma. Frontiers in Bioscience-Landmark. 28(9). 224–224. 1 indexed citations
4.
Lu, Xiaolan, et al.. (2023). Bilirubin is a superior biomarker for hepatocellular carcinoma diagnosis and for differential diagnosis of benign liver disease. Journal of Laboratory Medicine. 47(5). 233–241. 2 indexed citations
5.
6.
Tang, Hailin, Qianfa Long, Kun Zhuang, et al.. (2021). Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/CXCR4 axis by regulating autophagy in gastric cancer. Pathology - Research and Practice. 224. 153532–153532. 6 indexed citations
7.
Zhang, Cuiping, Meng Ding, Tingting Chen, et al.. (2019). Comprehensive analysis of differentially expressed serum microRNAs in humans responding to Brucella infection. Annals of Translational Medicine. 7(14). 301–301. 7 indexed citations
8.
Ding, Meng, Xiaolan Lu, Cheng Wang, et al.. (2018). The E2F1–miR-520/372/373–SPOP Axis Modulates Progression of Renal Carcinoma. Cancer Research. 78(24). 6771–6784. 32 indexed citations
9.
Chen, Tingting, Cheng Wang, Hanqing Yu, et al.. (2018). Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome. EBioMedicine. 39. 552–561. 51 indexed citations
10.
11.
Ding, Meng, Cheng Wang, Xiaolan Lu, et al.. (2018). Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling. Analytical and Bioanalytical Chemistry. 410(16). 3805–3814. 132 indexed citations
12.
Kuang, Gaizhen, Zhiyun Zhang, Shi Liu, et al.. (2017). Biphasic drug release from electrospun polyblend nanofibers for optimized local cancer treatment. Biomaterials Science. 6(2). 324–331. 68 indexed citations
13.
Wang, Yan, Yuanyuan Ding, Jingmei Li, et al.. (2017). Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy. Cellular Physiology and Biochemistry. 42(4). 1645–1656. 15 indexed citations
14.
Li, Xue, Juntao He, Ning Gao, et al.. (2017). Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. Scientific Reports. 7(1). 45176–45176. 232 indexed citations
15.
Geng, Yan, et al.. (2016). MicroRNA-27b suppresses Helicobacter pylori-induced gastric tumorigenesis through negatively regulating Frizzled7. Oncology Reports. 35(4). 2441–2450. 48 indexed citations
16.
Yang, Hua, Ya Liu, Xiaolan Lu, Xiaohui Li, & Haigang Zhang. (2013). Transmembrane transport of the Gαq protein carboxyl terminus imitation polypeptide GCIP-27. European Journal of Pharmaceutical Sciences. 49(5). 791–799. 8 indexed citations
17.
Liu, Ya, Fei Hao, Haigang Zhang, et al.. (2013). Panax NotoginsengSaponins Promote Endothelial Progenitor Cell Mobilization and Attenuate Atherosclerotic Lesions in Apolipoprotein E Knockout Mice. Cellular Physiology and Biochemistry. 32(4). 814–826. 24 indexed citations
18.
19.
Jiang, Ying, et al.. (2001). Fatty acids inhibit growth-factor-induced diacylglycerol kinase α activation in vascular smooth-muscle cells. Biochemical Journal. 357(1). 275–275. 23 indexed citations
20.
Lu, Xiaolan, et al.. (1998). Downregulation of platelet-derived growth factor receptor-β in Shp-2 mutant fibroblast cell lines. Oncogene. 17(4). 441–448. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kun Ren Breakdown of academic impact, for papers by Yuting Wang Breakdown of academic impact, for papers by Hongli Yan Breakdown of academic impact, for papers by Wanqian Li Breakdown of academic impact, for papers by Amir Savardashtaki Breakdown of academic impact, for papers by Shilong Zhang Breakdown of academic impact, for papers by Xiaohui Ma Breakdown of academic impact, for papers by Fangming Song Breakdown of academic impact, for papers by Binbin Cheng Breakdown of academic impact, for papers by Zhipeng Su
Rankless by CCL
2026